MAPT and Alzheimer disease: Hypothermia is a common outcome observed in several human diabetic populations [11]. Hence, another potential underlying mechanism for the increased tau hyperphosphorylation, thereby increased risk of dementia and AD, in the diabetic condition could be related to PP2A inhibition.